Actively Recruiting

Early Phase 1
Age: 18Years +
All Genders
NCT07560878

Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

Led by Mclean Hospital · Updated on 2026-05-13

80

Participants Needed

1

Research Sites

246 weeks

Total Duration

On this page

Sponsors

M

Mclean Hospital

Lead Sponsor

N

National Institute of Mental Health (NIMH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Many people with depression do not get better with standard treatments like medication. One promising alternative is transcranial magnetic stimulation (TMS), a non-invasive procedure that uses magnetic pulses to stimulate specific brain regions. A particular pattern of TMS called continuous theta-burst stimulation (cTBS) is thought to reduce overactive brain activity in depression, but the investigators do not yet fully understand how it works at the level of brain cells and connections. This study aims to determine the biological mechanism by which cTBS changes brain activity in people with depression. Specifically, the investigators are testing two competing ideas: (1) that cTBS works by weakening the connections between brain cells through a process called long-term depression (LTD), which is driven by a chemical messenger system called glutamate; or (2) that cTBS works by increasing the brain's natural "braking" system, driven by a different chemical messenger called GABA. To test these ideas, participants with depression will receive cTBS along with one of four FDA-approved medications, or placebo, that either boost or block these chemical messenger systems. The investigators will measure changes in brain activity using electroencephalography (EEG) recorded simultaneously with TMS. Specific patterns in the EEG signal, called TMS-evoked potentials (TEPs), act as a window into how different brain cell types are responding to stimulation. Each participant will complete four study visits, each testing a different drug-TMS combination in random order. One group of participants will test drugs targeting the glutamate system (d-cycloserine and memantine). A second group will test drugs targeting the GABA system (lorazepam and baclofen). All drugs are given as a single oral dose and are commonly used in clinical practice. Understanding exactly how cTBS works at a biological level could open the door to more effective, personalized TMS treatments.

CONDITIONS

Official Title

Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Can safely receive TMS and study drugs
  • Stable medication regimen for one month prior to study participation and throughout the study
  • Not currently receiving TMS, ECT, or ketamine treatments
  • No active safety concerns related to suicidality
  • Moderate to severe Major Depressive Disorder confirmed by specific questionnaires
Not Eligible

You will not qualify if you...

  • History of seizures or epilepsy
  • History of intracranial pathology or brain lesions
  • History of traumatic brain injury with loss of consciousness over 15 minutes
  • Signs of increased intracranial pressure
  • Major neurological conditions such as recent stroke, tumor, or neurodegenerative disorders
  • Major medical conditions that increase risk of emergency during a seizure (e.g., cardiac issues, asthma)
  • Severe migraines causing intolerance to treatment
  • Unable to tolerate MRI procedures
  • Pregnancy
  • Known allergy to d-cycloserine, baclofen, memantine, or lorazepam

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

McLean Hospital

Belmont, Massachusetts, United States, 02478

Actively Recruiting

Loading map...

Research Team

P

Prem Ganesh, MS

CONTACT

D

Dennis W Guevara

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

6

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here